DIANE HANKS: Open Payments
NPI 1699747717 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 51 payments from 14 companies in 2025. Trend: 2023 $1,051 · 2024 $749 · 2025 $1,173
Food & beverage: $1,061Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $186 |
| ABBVIE INC. | 6 | $156 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Alkermes, Inc. | 4 | $88 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
Products named: VRAYLAR, Auvelity, TRINTELLIX, CAPLYTA, INVEGA SUSTENNA, INGREZZA, Qelbree, ARISTADA.
Industry payments across WA — which companies pay providers there.
